French Manufacturer Releases Promising Phase 3 Clinical Trial Results for Chikungunya Vaccine: VLA1553
The French manufacturer of a vaccine for SARS-CoV-2, which induces Covid-19, which is marketed in Spain, has just released the results of the first phase 3 clinical trial of a candidate preparation for the chikungunya virus. This pathogen is endemic in some countries in Africa, Asia and Latin America. The future vaccine is, according to … Read more